A correlation of computed tomography perfusion and histopathology in tumor edges of hepatocellular carcinoma

被引:8
作者
Bai, Rong-Jie [1 ]
Li, Jin-Ping [2 ]
Ren, Shao-Hua [3 ]
Jiang, Hui-Jie [2 ]
Liu, Xin-Ding [2 ]
Ling, Zai-Sheng [2 ]
Huang, Qi [4 ]
Feng, Guang-Long [2 ]
机构
[1] Peking Univ, Dept Radiol, Beijing Jishuitan Hosp, Clin Med Coll 4, Beijing 100035, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Dept Radiol, Harbin 150086, Peoples R China
[3] First Hosp Harbin, Dept Radiol, Harbin 150010, Peoples R China
[4] Harbin Med Univ, Dept Pathol, Harbin 150086, Peoples R China
关键词
hepatocellular carcinoma; tumor edge; computed tomography; X-ray computer; histopathology; perfusion imaging; FUNCTIONAL-CT; HEPATITIS-B; LIVER; ANGIOGENESIS; EXPRESSION; DIAGNOSIS;
D O I
10.1016/S1499-3872(14)60298-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: The peripheral morphologic characteristics of hepatocellular carcinoma (HCC) reflect tumor growth patterns. Computed tomography (CT) perfusion is a new method to analyze hemodynamic changes in tissues. We assessed the relationship between CT perfusion and histopathologic findings in the periphery of HCC lesions. METHODS: Non-contrast CT, enhanced dual-phase CT, and CT perfusion were performed on 77 subjects (47 patients and 30 controls). Based on the imaging findings of enhanced dual-phase CT, the tumor edges were classified into three types: type I (sharp); type II (blurry); and type III (mixed). The CT perfusion parameters included hepatic blood flow, hepatic arterial fraction, hepatic arterial perfusion, and hepatic portal perfusion. The tissue sections from resected specimens were subjected to routine hematoxylin and eosin staining and immunohistochemical staining for CD34. The correlations between microvessel density (MVD) and the CT perfusion parameters were analyzed using Pearson's product-moment correlation coefficient. Changes in the perfusion parameters in tumor edges of different tumor types were evaluated. RESULTS: Type I (sharp): the pathologic findings showed fibrous connective tissue capsules in the tumor edges, and an MVD <= 30/mm(2). Type II (blurry): the histology showed that the edges were clear with no capsules and an MVD >30/mm(2). Type III (mixed): the pathology was similar to that of types land II, and an MVD >30/mm(2). Hepatic blood flow, hepatic arterial fraction, hepatic arterial perfusion, and hepatic portal perfusion were significantly increased in the tumor edges of HCC patients compared to those of the controls (P<0.05). The correlation between CT perfusion parameters and MVD was higher in blurry tumor edges of type II than in those of types I or III. CONCLUSION: CT perfusion imaging of tumor edges may be helpful in revealing histopathological features, and indirectly reflect angiogenic changes of HCCs.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 50 条
[21]   Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization [J].
Gerd Gr?zinger ;
Michael Bitzer ;
Roland Syha ;
Dominik Ketelsen ;
Konstantin Nikolaou ;
Ulrich Lauer ;
Marius Horger .
World Journal of Radiology, 2016, (07) :683-692
[22]   Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma [J].
Michael A. Fischer ;
Herman P. Marquez ;
Sonja Gordic ;
Bertil Leidner ;
Ernst Klotz ;
Peter Aspelin ;
Hatem Alkadhi ;
Torkel B. Brismar .
European Radiology, 2017, 27 :1074-1080
[23]   The value of computed tomography perfusion for assessing the response of hepatocellular carcinoma to transarterial chemoembolization [J].
Huynh, Bui Quang ;
Hung, Nguyen Duy ;
Dung, Le Thanh ;
Thu, Nguyen-Thi ;
Anh, Nguyen-Thi Hai ;
Duy, Ngo Quang ;
Duc, Nguyen Minh .
ITALIAN JOURNAL OF MEDICINE, 2024, 18 (03)
[24]   Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression [J].
Makino, Yuki ;
Imai, Yasuharu ;
Igura, Takumi ;
Hori, Masatoshi ;
Fukuda, Kazuto ;
Sawai, Yoshiyuki ;
Kogita, Sachiyo ;
Ohama, Hideko ;
Matsumoto, Yasushi ;
Nakahara, Masanori ;
Zushi, Shinichiro ;
Kurokawa, Masanori ;
Isotani, Keisuke ;
Takamura, Manabu ;
Fujita, Norihiko ;
Murakami, Takamichi .
HEPATOLOGY RESEARCH, 2013, 43 (09) :950-958
[25]   Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease [J].
Li, Jin-Ping ;
Zhao, De-Li ;
Jiang, Hui-Jie ;
Huang, Ya-Hua ;
Li, Da-Qing ;
Wan, Yong ;
Liu, Xin-Ding ;
Wang, Jin-E .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (01) :43-49
[26]   Early Antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma [J].
Zhu, Andrew X. ;
Holalkere, Nagaraj S. ;
Muzikansky, Alona ;
Horgan, Kerry ;
Sahani, Dushyant V. .
ONCOLOGIST, 2008, 13 (02) :120-125
[27]   Value of perfusion parameters and histogram analysis of triphasic computed tomography in pre-operative prediction of histological grade of hepatocellular carcinoma [J].
Shao, Chun-Chun ;
Zhao, Fang ;
Yu, Yi-Fan ;
Zhu, Lin-Lin ;
Pang, Guo-Dong .
CHINESE MEDICAL JOURNAL, 2021, 134 (10) :1181-1190
[28]   Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma [J].
Rastogi, Archana .
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (35) :4000-4013
[29]   Combined computed tomography and magnetic resonance imaging improves diagnosis of hepatocellular carcinoma ≤ 3.0 cm [J].
Chul-min Lee ;
Sang Hyun Choi ;
Jae Ho Byun ;
So Jung Lee ;
So Yeon Kim ;
Hyung Jin Won ;
Yong Moon Shin ;
Pyo-Nyun Kim .
Hepatology International, 2021, 15 :676-684
[30]   Combined computed tomography and magnetic resonance imaging improves diagnosis of hepatocellular carcinoma ≤ 3.0 cm [J].
Lee, Chul-min ;
Choi, Sang Hyun ;
Byun, Jae Ho ;
Lee, So Jung ;
Kim, So Yeon ;
Won, Hyung Jin ;
Shin, Yong Moon ;
Kim, Pyo-Nyun .
HEPATOLOGY INTERNATIONAL, 2021, 15 (03) :676-684